|
Press Releases |
|
 |
|
Thursday, March 20, 2025 |
|
Sino Biopharm (1177.HK) Announces 2024 Annual Results |
Sino Biopharmaceutical Limited ('Sino Biopharm' or the 'Company', together with its subsidiaries, the 'Group') (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2024. more info >> |
|
Wednesday, August 14, 2024 |
|
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results |
Sino Biopharmaceutical Limited (?Sino Biopharmaceutical? or the ?Company?, together with its subsidiaries, the ?Group?) (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited interim results for the six months ended 30 June 2024 (the ?Period?). more info >> |
|
Friday, March 29, 2024 |
|
Sino Biopharm (1177.HK) Announces 2023 Annual Results |
Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2023. more info >> |
|
Friday, August 25, 2023 |
|
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited interim results for the six months ended 30 June 2023 (the "Period"). more info >> |
|
Friday, March 31, 2023 |
|
Sino Biopharm (1177.HK) Announces 2022 Annual Results |
Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2022. more info >> |
|
Tuesday, August 23, 2022 |
|
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited Interim results for the six months ended 30 June 2022 (the "Period"). more info >> |
|
Thursday, July 22, 2021 |
|
Sino Biopharmaceutical Donates Cash and Supplies Valued at RMB10 Million to Support Henan for Flood Relief and Preventing Epidemic |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced the donation of cash and supplies valued at RMB10 million to support Henan for flood relief and preventing epidemic. more info >> |
|
Monday, May 24, 2021 |
|
Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2021. more info >> |
|
Tuesday, March 23, 2021 |
|
Sino Biopharmaceutical 2020 Net Profit Grows to RMB2.77 Billion amid Adversity |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited annual results for the year ended 31 December 2020. more info >> |
|
Monday, December 7, 2020 |
|
Sino Biopharm Invests in Sinovac LS, A Leading COVID-19 Vaccine Company in China |
Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Group"; HKEX: 1177) has announced the investment of US$515 million in Sinovac Life Sciences Co., Ltd. ("Sinovac LS", previously known as Sinovac Research and Development Co., Ltd.), which will be funded by internal resources of the Group and result in a 15.03% equity interest in Sinovac LS. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Shiv Khera's New Book "Live While You're Alive" Launched in Singapore
Jun 3, 2025 15:00 HKT/SGT
|
|
|
20 Start-ups Showcase at Hong Kong Tech Pavilion in VivaTech 2025
Jun 3, 2025 11:57 HKT/SGT
|
|
|
Anime Tokyo Station Launches Official YouTube Channel
Jun 3, 2025 11:00 JST
|
|
|
Luxren Capital Introduces a New Era in Mobile Trading: Secure, Regulated, and Always at Users' Fingertips
Jun 3, 2025 05:00 HKT/SGT
|
|
|
IFEX Capital Introduces Its Latest Version of a Groundbreaking Trading Platform Connecting Traders Globally
Jun 2, 2025 22:00 HKT/SGT
|
|
|
NEXX Signs Joint Memorandums of Understanding (MoU) with Milaha and KEC
Jun 2, 2025 19:06 HKT/SGT
|
|
|
New Habitat for Humanity report shows housing improvements in informal settlements promotes health outcomes of women
Jun 2, 2025 19:00 HKT/SGT
|
|
|
Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 months with Individualized Cancer Vaccine TG4050
Jun 2, 2025 17:56 JST
|
|
|
Eisai to Launch "Pariet S," the First Proton Pump Inhibitor RX-to-OTC in Japan
Jun 2, 2025 17:46 JST
|
|
|
New HKTDC Chairman Professor Frederick Ma Si-Hang meets with management team
Jun 2, 2025 16:35 HKT/SGT
|
|
|
Mitsubishi Corporation to Invest and Enter into a Business Partnership with DEScycle Ltd., a UK Company Developing Innovative Metal Recycling Technology
Jun 2, 2025 14:35 JST
|
|
|
MyJCB App Wins Gold at A' Design Award & Competition
Jun 2, 2025 12:00 JST
|
|
|
Fujitsu Technology Park's redevelopment project launch
Jun 2, 2025 11:23 JST
|
|
|
Wasion Holdings Subsidiaries Secure Over HK$253 Million in Contracts from State Grid's 2025 First Metering Equipment Tender
Jun 2, 2025 09:43 HKT/SGT
|
|
|
TransNusa Increases Scheduled Flight Frequency to Twice Daily
Jun 2, 2025 08:30 HKT/SGT
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|